When a threshold of 5 μg/L for the serum CEA was used, the pooled sensitivity of the CEA for CRC recurrence was 71%, with a specificity of 88%; however, approximately 25% of recurrences occur without an accompanying increase in the serum CEA concentration [6]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.